Roche Wins FDA Nod for Breast Cancer Drug in First-Line Setting
Roche (RHHBY Quick QuoteRHHBY - Free Report) announced that the FDA has approved pipeline candidate, inavolisib, for the treatment of breast cancer, under the brand name Itovebi.Year to date, Roche’s…